報價延遲最少15分鐘:2025/07/05 21:38 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
28.12 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.06/2.48
|
|
企業價值
26.38B
|
| 資產負債 |
|
每股賬面淨值
28.72
|
| 現金流量 |
|
現金流量率
0.17
|
| 損益表 |
|
收益
19.34B
|
|
每股收益
35.11
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/05 21:38 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourthsof sales, while the balance is generated from medical technology products that enable dialysis treatments. |